XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 26.40

-0.6%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Robert K. who wrote (10728)	7/11/1999 11:01:00 AM
From: aknahow	of 17367

Robert, my post is related to un blinding the data. Even XOMA has confirmed Murphy's statement that they will be able to unblind after all subjects in the trial have reached the 60 day look back period. XOMA has not told Murphy they will unblind on July 13 , only that unblinding will occur between July 13 and Aug. 13. According to Murphy XOMA has no plans to say anything more to shareholders than they are going to apply for a BLA. Unblinding early carries a cost. The data, for those that have not reached a specific look back point, is, of course, not lost. It just cannot be used as part of the application to support drug approval. Data from these patients can be used for any points already reached when unblinding occurred. Robert do you know if, under subpart E, a company is at liberty to decide when to unblind? Does any company, understanding the cost in data, have this ability? Not implying that they do, just that many posters do not know and it would be of interest to understand this in general.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next